Behavioral and Cognitive Response to Selective Serotonin Reuptake Inhibitors in Frontotemporal Lobar Degeneration: A Systematic Review and Meta-analysis
- 1 September 2021
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 44 (5) , 175-183
Abstract
Objective: This article systematically reviews current literature on the efficacy and efficiency of selective serotonin reuptake inhibitors (SSRIs) in the treatment of patients with frontotemporal lobar degeneration (FTLD), with a particular focus on behavior and cognitive functions. Methods: A search was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines using CENTRAL, MEDLINE, and Cochrane Library databases. Eleven randomized controlled trials and open-label studies looking at the effects of SSRIs on FTLD patients were included. A random-effects meta-analysis was performed, consisting of 3 randomized and controlled studies that used the neuropsychiatric inventory to assess SSRI intervention. Results: The meta-analysis shows a combined mean reduction of 10.17 points (95% confidence interval, 18.14–2.19; P = 0.01) on the neuropsychiatric inventory with SSRI treatment in FTLD patients. The I 2 calculated for this study was 62% (P = 0.07), which represents moderate heterogeneity among the studies. The Egger regression test (P = 0.526) did not show a publication bias. Sensitivity analysis showed no significant change. Conclusions: The current meta-analysis supports SSRIs as an intervention for management of behavioral symptoms of FTLD. Marked improvements were seen in disinhibition, irritability, aggression, and aberrant motor activity across studies. However, apathy/loss of empathy did not show similarly promising results. A deteriorative effect on cognition was seen associated with SSRI use.Keywords
This publication has 38 references indexed in Scilit:
- Cognitive Outcomes After Sertaline Treatment in Patients With Depression of Alzheimer DiseaseThe American Journal of Geriatric Psychiatry, 2012
- Management of Frontotemporal Dementia: Targeting Symptom Management in Such a Heterogeneous Disease Requires a Wide Range of Therapeutic OptionsNeurodegenerative Disease Management, 2011
- Frontotemporal Lobar DegenerationCNS Drugs, 2010
- Behavioural abnormalities associated with rapid deterioration of language functions in semantic dementia respond to sertralineJournal of Neurology, Neurosurgery & Psychiatry, 2009
- MMSE Scores Decline at a Greater Rate in Frontotemporal Degeneration than in ADDementia and Geriatric Cognitive Disorders, 2006
- Natural History of Frontotemporal Dementia: Comparison with Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 2004
- Efficacy of Fluvoxamine as a Treatment for Behavioral Symptoms in Frontotemporal Lobar Degeneration PatientsDementia and Geriatric Cognitive Disorders, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Frontotemporal Dementia: Paroxetine as a Possible Treatment of Behavior SymptomsEuropean Neurology, 2002
- Frontotemporal dementia: patient characteristics, cognition, and behaviourInternational Journal of Geriatric Psychiatry, 2002